BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.630
0.00 (0.00%)
Sep 23, 2026, 10:01 AM EDT - Market open
BioVie Market Cap
BioVie has a market cap or net worth of $12.29 million as of September 23, 2026. Its market cap has decreased by -13.42% in one year.
Market Cap
12.29M
Enterprise Value
3.59M
1-Year Change
-13.42%
Ranking
Category
Stock Price
$1.63
ChartMarket Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $12.29M, a decrease of -76.36%. That is a compound annual growth rate of -21.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 12.29M | 41.32% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 13.12M |
| GT Biopharma | 12.96M |
| Tempest Therapeutics | 12.80M |
| CalciMedica | 12.70M |
| AEON Biopharma | 12.67M |
| Daré Bioscience | 12.38M |
| NeuroSense Therapeutics | 12.24M |
| Enlivex | 12.11M |